Enhancement of anti-tumour immunity in syngeneic mice after MHC class II gene transfection
1996

Enhancing Anti-Tumor Immunity in Mice with MHC Class II Gene Transfection

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): C Mongini, M S'anchez Lockhart, CI Waldner, EMC Alvarez, MJ Gravisaco, MI Roig, SE Hajos

Primary Institution: Catedra de Immunologia, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires

Hypothesis

Does the transfection of MHC class II genes into a murine leukemia cell line enhance anti-tumor immunity?

Conclusion

Transfecting MHC class II genes into tumor cells significantly enhances the anti-tumor immune response in syngeneic mice.

Supporting Evidence

  • Transfected cells showed enhanced expression of MHC class II molecules.
  • Mice injected with transfected cells had a significantly higher survival rate.
  • Specific cytotoxic T cell responses were significantly increased in mice immunized with transfected cells.

Takeaway

Scientists found that adding a special gene to cancer cells helps the immune system fight the cancer better, making it harder for the cancer to grow.

Methodology

Mice were injected with transfected tumor cells, and their immune response was measured through survival rates and cytotoxic T cell activity.

Limitations

The study was conducted in a specific mouse model, which may not fully represent human responses.

Participant Demographics

Two to four month old normal BALB/c mice were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication